The Claim
Under glucose limitation, MUC1-overexpressing pancreatic cancer cells accumulate glutamine-derived aspartate but fail to convert it into pyrimidine nucleotides, resulting in disrupted DNA synthesis and proliferation arrest.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When glucose is scarce, pancreatic cancer cells with high levels of MUC1 build up a molecule called aspartate from glutamine but cannot use it to make DNA building blocks, which stops the cells from multiplying.
See the scientific wording
Under glucose limitation, MUC1-overexpressing pancreatic cancer cells accumulate glutamine-derived aspartate but fail to convert it into pyrimidine nucleotides, disrupting DNA synthesis and contributing to proliferation arrest.
When sugar is scarce, these cancer cells pull in more glutamine and turn it into aspartate, a building block for DNA. But without sugar, they cannot use that aspartate to make the actual DNA components. The aspartate piles up, DNA cannot be made, and the cells stop dividing.
What the research says
1 studyStudy: Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells
When sugar is low, these cancer cells with extra MUC1 make a lot of a molecule needed to build DNA, but they can't turn it into actual DNA parts — so they can't multiply. It's like having all the bricks but no cement to build with.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.